Scs Vision Net Worth & Insider Trades

Scs Vision Cullinan Oncology, Inc

As of August 4, 2022

What is Scs Vision's Net Worth?

The current estimated net worth of Cullinan Oncology, Inc's Scs Vision is estimated to be about $6.08M . Scs Vision owns about 1,463,766 units of Cullinan Oncology, Inc common stock. In the last year at Cullinan Oncology, Inc, Scs Vision has sold an estimated value of $4.76M worth.

What is Scs Vision's Past Insider Trading?

Scs Vision's largest purchase order was 6,026,832 units , worth over $4.2M on January 14, 2021. Scs Vision's largest sale order was 418,738 units , worth over $4.05M on May 16, 2022. In total, Scs Vision has made about 4 transactions over a year of their time at Cullinan Oncology, Inc. Scs Vision usually trades in January, with the busiest year in 2022. The most recent transaction was a sale order of 49,910 units , worth over $711.68K on August 4, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Scs Vision's' Mailing Address?

  • Mailing address is 74 Grand Rue Luxemburg N4 L-1660 Luxembourg

Cullinan Oncology, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Owen Hughes 2020 $461,250 $245,063 $530,320 $5,301,175 $14,250 $6,552,058
Owen Hughes 2019 $450,000 $96,800 - - $14,000 $560,800
Patrick Bauerle, Ph.D. 2020 $436,997 $266,131 $491,284 $4,124,284 $34,800 $5,353,497
Patrick Bauerle, Ph.D. 2019 $420,895 $107,502 - - $34,400 $562,797
Jon Wigginton, M.D. 2020 $321,122 $258,000 - $3,959,525 $5,375 $4,544,022
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1789972/000119312521140630/d170327ddef14a.htm

What are Cullinan Oncology, Inc's Past Insider Trades?

Cullinan Oncology, Inc's most recent insider trade came on August 9, 2022 by Jennifer Michaelson who sold 1,385 units worth $20.79K . In the last year, insiders at Cullinan Oncology, Inc have sold an estimated value of $28.88M and bought an estimated value of $39.24M worth of shares. Insider trading is most common in September, with the busiest year in 2021. The most active traders at the company are Ansbert Gadicke, Director,  Bioimpact Capital Llc,  and Oncology Impact Fund Cayman Management Lp .

Cullinan Oncology, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1